Local and Intraperitoneal Analgetics in Gynecologic Laparoscopy for Post Operative Pain Relief
NCT ID: NCT02976571
Last Updated: 2018-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2016-11-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraperitoneal Atomization of Ropivacaine During Gynecologic Laparoscopic Surgery
NCT01623635
Intraoperative and Postoperative Analgesia for Laparoscopic Surgery.
NCT00772187
Post-operative Pain Relief in Laparoscopic Cholecystectomy
NCT03355716
Comparison of the Efficacy of Intraperitoneal Instillation of Fentanyl Versus Nalbuphine As Adjuvants to Bupivacaine for Postoperative Pain Relief in Patients Undergoing Laparoscopic Cholecystectomy
NCT06722963
Comparing Protocols for Analgesia Following Elective Cesarean Section
NCT03622489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sub cutaneous+Intraperitoneal
Sub cutaneous Bupivacaine+ Intraperitoneal bupivacaine
Bupivacaine
Sub cutaneous and/or Intraperitoneal Marcaine application
Sub cutaneous+Placebo
Sub cutaneous Bupivacaine+ Intraperitoneal Nacl 0.9%
Bupivacaine
Sub cutaneous and/or Intraperitoneal Marcaine application
Placebo+Intraperitoneal
Sub cutaneous Nacl 0.9%+ Intraperitoneal bupivacaine
Bupivacaine
Sub cutaneous and/or Intraperitoneal Marcaine application
Placebo+Placebo
Sub cutaneous Nacl 0.9%+ Intraperitoneal Nacl 0.9%
Bupivacaine
Sub cutaneous and/or Intraperitoneal Marcaine application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
Sub cutaneous and/or Intraperitoneal Marcaine application
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wolfson Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ohad Gluck, MD
Role: PRINCIPAL_INVESTIGATOR
Wolfson Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wolfson medical center
Holon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Gluck O, Barber E, Feldstein O, Tal O, Kerner R, Keidar R, Wolfson I, Ginath S, Bar J, Sagiv R. The effect of subcutaneous and intraperitoneal anesthesia on post laparoscopic pain: a randomized controlled trial. Sci Rep. 2021 Jan 8;11(1):81. doi: 10.1038/s41598-020-80130-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0198-16-WOMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.